Providing Cervical Cancer Screening to HIV seropositive women in Sub- Saharan Africa - a study of integrated services.
Nyhus, H. (2014) Providing Cervical Cancer Screening to HIV seropositive women in Sub- Saharan Africa - a study of integrated services., no. 56.
Cervical cancer is the second most common cancer in women worldwide, with significantly higher incidence rates among HIV seropositive women. In multiple countries situated in the Sub- Sahara African region, a double burden of cervical cancer and HIV is growing. It is argued that without sufficient cervical cancer prevention the existing number of deaths attributed to this cancer will double by 2030. Without the possibility to offer organised population based screening due to constrains currently challenging the health systems within the region, innovative approaches integrating services linking cervical cancer screening and HIV care are now being implemented in different settings within the Sub- Sahara African context. Taking advantage of the synergy established between cervical cancer and HIV, these approaches uses established HIV care platforms to deliver cervical cancer screening as these can offer physical infrastructure, human resources and medical supplies. This study aims to investigate to what extent these integrated service approaches, currently operationalized within the region, optimises cervical cancer screening delivery and health related outcomes for HIV infected women, and if it is feasible to further bring this approach to scale in the SSA region. To answer this, a literature review is conducted to identify where current initiatives delivering integrated service are situated and how they are operationalized. An organisational framework is then used to the explore health outcomes, and barriers to these, at different levels of the health care system. Further the study discusses how these outcomes can be put forward as evidence of programme feasibility. The primary audience for this study is health professionals, health policymakers and researchers as the study can be useful in understanding the optimal way of delivering cervical cancer screening to HIV seropositive women.